In the first part of his Pharma Commerce video interview, Arthur Axelrad, co-founder and CEO of Dispatch Science, discusses ...
Haub School of Business, shares why wholesalers remain indispensable to pharmaceutical distribution—supporting cold chain ...
Samsung Biologics acquires Human Genome Sciences from GSK for $280 million, expanding its US manufacturing footprint. The ...
In the first part of her Pharma Commerce video interview, Tina Martinez, vice president and head of global products and ...
In today’s Pharma Pulse, major pharma players commit to most-favored-nation pricing, as DHL bolsters West Coast logistics for ...
In today’s Pharma Pulse, Novo Nordisk secures a landmark approval for a weight-loss pill, while Yusen Logistics expands its ...
Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...
In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a ...
In today’s Pharma Pulse, the FDA approves Amgen’s Uplizna (inebilizumab-cdon), the first CD19-targeted therapy for gMG with convenient twice-yearly dosing, and much more. Welcome to Pharma Pulse, a ...
Practical guidance was provided on optimizing wholesale acquisition cost, pricing governance, and access-focused strategies to enhance commercial performance and patient affordability. The session ...
Yusen Logistics (Europe), an overseas subsidiary of Yusen Logistics Group, has officially completed the purchase of the ...
Reform in the pharmacy benefit model should prioritize industry collaboration over government price controls, which can hinder innovation and adaptability. Transparency in pricing and patient outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback